Product Detail
Acute Myelogenous Leukemia
Nagarajan, Lalitha
Pricing & Availability
Available: 0
List Price:$319.00
Other formats:
E E Book + ProQuest Ebook Central
All Formats
Book Information
Edition:
1st
Publisher:
Springer Nature
ISBN:
0-387-69257-6 (0387692576)
ISBN-13:
978-0-387-69257-9 (9780387692579)
Binding:
Hardcover
Copyright:
2010
Publish Date:
01/10
Volume:
145
Weight:
1.21 Lbs.
Pages:
280
Subject Class:
ONC (Oncology)
Remarks:
Print on Demand. Please allow additional time for delivery.
Return Policy:
Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Table Of Contents:
View
Contributing Authors:
View
ProQuest Ebook Central:
Available in ProQuest Ebook Central™
View
Class Specifications
ISSN Series:
Cancer Treatment and Research
Discipline:
Hematology
Subject Definition:
Leukemia, Myeloid, Acute
NLM Class:
WH 250
LC Class:
RC643
Abstract:
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered.
close
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews
Privacy Statement
Available in ProQuest Ebook Central™ View